macaqu
repres
major
nonhuman
primat
resourc
biomed
research
nation
institut
health
nih
nation
primat
research
center
nprc
provid
effect
infrastructur
suppli
hous
total
mostli
macaqu
macaca
benefit
research
human
diseas
nhp
speci
africa
eg
african
green
sooti
mangabey
monkey
baboon
chimpanze
new
world
eg
marmoset
spider
owl
monkey
also
hous
nprc
facil
contribut
significantli
research
aid
infecti
diseas
applic
mention
nhp
speci
relev
infecti
diseas
section
speci
macaqu
found
primarili
southern
asia
napier
napier
omnivor
adapt
almost
ecolog
nich
adapt
well
captiv
speci
commonli
use
biomed
research
rhesu
macaqu
mulatta
india
longer
import
cynomolgu
longtail
crabeat
macaqu
fasciculari
southern
asia
pigtail
macaqu
nemestrina
southeast
asia
nih
nation
center
research
resourc
ncrr
plan
increas
number
macaqu
breed
coloni
includ
specif
pathogenfre
spf
anim
set
databas
enabl
research
locat
anim
particular
characterist
ncrr
experiment
induc
infecti
diseas
close
relat
primat
occasion
studi
natur
occur
infect
investig
hope
cours
gain
valuabl
insight
relev
human
diseas
mechan
develop
improv
therapi
diagnost
vaccin
opportun
hand
better
achiev
goal
recent
avail
sequenc
macaqu
genom
rhesu
macaqu
genom
sequenc
analysi
consortium
genom
mani
infecti
pathogen
insect
vector
particular
much
new
inform
obtain
agenthost
relationship
use
macaquespecif
nucleic
acid
protein
assay
articl
review
variou
human
infecti
diseas
macaqu
serv
model
past
centuri
model
repres
divers
pathogen
includ
bacteria
virus
fungi
parasit
prion
categor
specif
agent
tabl
base
recent
survey
explor
origin
human
infecti
diseas
wolf
et
al
broad
categori
diseas
order
accord
viral
bacteri
parasit
etiolog
accord
histor
preced
relat
infecti
agent
diseas
also
includ
sever
nhp
infecti
agent
produc
diseas
similar
relat
human
pathogen
mani
pathogen
human
zoonos
diseas
transmit
anim
human
sever
zoonot
pathogen
transmit
directli
human
human
particular
zoonot
infect
major
sourc
emerg
reemerg
diseas
worldwid
murphi
palmer
et
al
wolf
et
al
furthermor
human
pathogen
call
anthropozoonos
spread
accident
nhp
macaqu
model
infecti
pathogen
describ
review
mention
import
histor
event
current
relev
human
diseas
focu
uptod
research
accomplish
space
limit
describ
primarili
recent
novel
exampl
infecti
diseas
model
captiv
macaqu
speci
accordingli
cite
refer
repres
mean
comprehens
refer
reader
publish
resourc
inform
human
infecti
agent
includ
virus
graff
knipe
et
al
bacteria
mandel
et
al
parasit
marquardt
et
al
well
histor
impact
pathogen
karlen
oldston
goal
focu
macaqu
immens
valuabl
resourc
wide
spectrum
compar
infecti
diseas
research
benefit
human
anim
although
fm
burnet
show
earli
macaqu
suscept
influenza
viru
graff
princip
anim
model
extens
immun
trial
strain
type
remain
ferret
mice
recent
research
use
macaqu
compar
pathogenesi
highli
virul
influenza
strain
reconstruct
pandem
strain
pathogen
bird
flu
strain
nonvirul
convent
strain
rimmelzwaan
et
al
genom
proteom
technolog
macaquespecif
reagent
shown
dramat
differ
gene
express
pulmonari
lesion
induc
influenza
viru
tightli
coregul
gene
express
peripher
white
blood
cell
might
prove
marker
earli
infect
baa
et
al
appar
cytokin
storm
trigger
alveolar
damag
viru
replic
lung
induc
acut
respiratori
distress
syndrom
multipl
organ
dysfunct
remot
site
free
viru
rimmelzwaan
et
al
similar
transcriptom
approach
reveal
virul
strain
influenza
viru
induc
lethal
respiratori
infect
associ
atyp
innat
immun
respons
abnorm
antivir
respons
kobasa
et
al
better
understand
virushost
interact
macaqu
aid
develop
intervent
modul
host
innat
immun
respons
virul
influenza
viru
facilit
earli
diagnosi
novel
live
vaccin
incorpor
hemagglutinin
influenza
viru
gene
avian
newcastl
diseas
viru
vector
given
via
respiratori
tract
african
green
monkey
induc
high
level
neutral
antibodi
therefor
consid
candid
clinic
evalu
human
dinapoli
et
al
natur
infect
hav
associ
mild
clinic
diseas
detect
newli
caught
macaqu
le
bra
et
al
shevtsova
et
al
whether
rhesu
human
origin
hav
also
caus
experiment
infect
littl
evid
mild
hepat
macaqu
mao
et
al
howev
newli
captur
monkey
sensit
hav
associ
acut
chronic
liver
diseas
presum
due
stress
acclimat
compel
need
advanc
macaqu
model
efficaci
hav
vaccin
licens
sinc
natur
infect
hbvlike
viru
associ
mild
hepat
observ
recent
import
cynomolgu
macaqu
indonesia
kornegay
et
al
rhesu
macaqu
experiment
infect
human
hbv
evid
liver
damag
barker
et
al
zuckerman
et
al
howev
macaqu
morocco
sylvanu
develop
liver
patholog
intrahepat
inocul
replicationcompet
hbv
dna
plasmid
construct
gheit
et
al
highli
effect
hbv
vaccin
licens
sinc
need
anim
model
viru
hcv
major
caus
posttransfus
hepat
isol
clone
choo
et
al
mutat
hcv
genom
allow
viru
avoid
immun
surveil
outcom
chronic
infect
difficulti
produc
effect
vaccin
cynomolgu
rhesu
japanes
macaqu
resist
experiment
hcv
infect
abe
et
al
therefor
chimpanze
suscept
remain
anim
model
choic
hcv
vaccin
research
howev
research
use
macaqu
model
hcv
immunogen
studi
particularli
effort
defin
vaccin
regimen
produc
stronger
cellular
immun
respons
capon
et
al
b
li
et
al
rollier
et
al
hev
emerg
human
pathogen
endem
southwest
central
asia
middl
east
north
africa
mexico
viru
spread
fecalor
rout
caus
signific
number
acut
hepat
case
human
includ
epidem
high
mortal
gener
howev
patient
recov
chronic
hev
infect
develop
natur
hev
infect
occur
asymptomat
japanes
macaqu
fuscata
may
transmiss
human
hirano
et
al
cynomolgu
rhesu
macaqu
quit
suscept
human
hev
subclin
infect
aggarw
et
al
graff
et
al
kawai
et
al
extens
use
recent
year
demonstr
protect
efficaci
sever
antivir
recombin
dna
vaccin
kamili
et
al
li
et
al
purcel
et
al
zhang
et
al
hgv
isol
distantli
relat
hcv
readili
transmit
blood
transfus
carrier
rate
gener
nhp
popul
rhesu
macaqu
suscept
experiment
infect
diseas
hgv
genom
rna
ren
et
al
xu
et
al
howev
evid
hgv
harm
human
need
develop
antihgv
vaccin
test
drug
resurg
mycobacterium
tuberculosi
mtb
major
global
caus
death
acceler
hiv
epidem
appear
multidrugresist
mtb
strain
improv
diagnost
drug
vaccin
need
macaqu
highli
suscept
human
mtb
well
bovin
avian
mycobacteria
manifest
complet
spectrum
clinic
patholog
manifest
human
activ
progress
diseas
latenc
heal
capuano
et
al
walsh
et
al
natur
outbreak
human
bovin
avian
tb
occur
repeatedli
year
captiv
macaqu
zump
et
al
fifti
year
ago
macaqu
use
demonstr
efficaci
bacillu
calmetteguerin
bcg
vaccin
attenu
strain
bovi
evalu
vaccin
approach
test
new
drug
lethal
challeng
mtb
good
schmidt
although
research
confirm
result
recent
year
langerman
et
al
neither
bcg
vaccin
drug
curtail
global
spread
tb
modern
macaquespecif
reagent
hand
model
resurrect
interferon
gamma
releas
antigenspecif
cell
provid
use
immunolog
correl
protect
mtb
infect
baskin
et
al
macaqu
model
help
better
defin
immunodomin
antigen
conserv
differ
mtb
strain
induc
maximum
protect
given
alon
togeth
bcg
brusasca
et
al
mcshane
et
al
antigen
could
becom
basi
better
diagnost
vaccin
macaqu
model
also
use
studi
coinfect
siv
counterpart
hiv
macaqu
experiment
coinfect
siv
bcg
exhibit
fatal
dissemin
diseas
character
bcg
granuloma
multipl
organ
chen
shen
et
al
hivinfect
human
infant
vaccin
bcg
also
experi
high
risk
develop
dissemin
bcg
diseas
von
reyn
world
health
organ
recommend
bcg
vaccin
hivinfect
children
sivinduc
compromis
adapt
cell
respons
may
contribut
tuberculosislik
diseas
zhou
et
al
understand
mtb
pathogenesi
macaqu
lead
better
manag
control
human
tb
epidem
macaqu
superior
anim
model
investig
pathogenesi
h
gastriti
gastric
cancer
kodama
et
al
half
world
popul
infect
h
pylori
bacterium
grow
stomach
acquir
oral
childhood
infect
exhibit
gastriti
stomach
ulcer
progress
stomach
cancer
h
pylori
secret
ureas
convert
urea
ammonia
reduc
gastric
acid
thu
enhanc
gastric
colon
h
pylori
inject
toxin
caga
gene
product
gastric
epitheli
cell
lead
disorgan
saadat
et
al
antibiot
effect
elimin
bacterium
host
therebi
prevent
complic
macaqu
proven
suitabl
model
understand
biolog
molecular
pathogenesi
h
pylori
macaqu
natur
infect
sever
strain
close
relat
human
also
highli
suscept
human
strain
doi
et
al
duboi
et
al
solnick
et
al
develop
gastriti
antral
eros
indistinguish
occur
human
reindel
et
al
shuto
et
al
macaqu
also
exhibit
atroph
gastriti
precursor
adenocarcinoma
human
captiv
rhesu
monkey
frequent
colon
relat
speci
h
cinaedi
either
asymptomat
associ
chronic
coliti
hepat
fernandez
et
al
modif
h
pylori
outer
membran
protein
express
occur
experiment
infect
solnick
et
al
may
facilit
epitheli
adher
promot
chronic
infect
analysi
gastric
transcript
profil
reveal
expect
upregul
cell
structur
element
inflammatori
immun
respons
well
novel
downregul
heat
shock
protein
huff
et
al
studi
also
demonstr
increas
express
virul
gene
thought
encod
h
pylori
type
iv
structur
pilu
accessori
protein
boonjakuakul
et
al
predomin
immun
respons
induc
earli
infect
may
associ
apoptosi
gastric
lymphocyt
epitheli
cell
mattapallil
et
al
tanaka
et
al
research
evalu
result
shortterm
antibiot
treatment
h
pylori
infect
intestin
microflora
macaqu
tanaka
et
al
sever
vaccin
strategi
includ
recombin
h
pylori
ureas
partial
protect
macaqu
infect
agent
duboi
et
al
macaqu
play
major
role
poliomyel
polio
research
particularli
vaccin
develop
graff
first
indic
poliomyel
agent
filter
viru
came
diseas
known
sinc
prehistori
experiment
induc
macaqu
inocul
filter
spinal
cord
infect
individu
human
known
natur
host
polioviru
viru
could
grown
tissu
cultur
nonhuman
primat
kidney
cell
african
green
monkey
vero
cell
order
type
differ
strain
polioviru
rhesu
macaqu
use
period
experiment
infect
serotyp
drew
wild
viru
strain
numer
anatom
sourc
monkey
sera
type
viru
neutral
assay
scientist
identifi
three
predomin
immulog
type
viru
type
preval
virul
cell
cultur
also
allow
demonstr
viremia
monkey
human
base
research
nhp
model
salk
inactiv
vaccin
well
koprowski
later
sabin
attenu
polio
vaccin
test
immunogen
safeti
efficaci
mani
thousand
human
children
proven
protect
safe
simian
vacuol
viru
polyomaviru
discov
contamin
inactiv
polioviru
vaccin
prepar
macaqu
cell
cultur
howev
conclus
evid
implic
viru
polio
vaccin
origin
human
diseas
shah
detect
sequenc
polymeras
chain
reaction
mesothelioma
meningioma
suggest
associ
relat
agent
certain
human
cancer
carbon
pass
white
et
al
evid
hiv
siv
polio
vaccin
stock
use
first
us
polio
immun
campaign
rizzo
et
al
exampl
revers
zoonosi
polio
type
outbreak
presum
human
origin
affect
six
monkey
nhp
coloni
sukhumi
russia
lapin
andreevna
human
infect
case
wild
polio
occur
countri
sinc
america
declar
poliofre
howev
polio
still
concern
poor
underdevelop
countri
africa
asia
use
macaqu
therefor
still
necessari
monitor
potenti
neurovirul
live
attenu
sabin
polio
vaccin
administ
primarili
develop
countri
rezapkin
et
al
revers
virul
remain
problem
live
attenu
vaccin
longer
given
unit
state
transgen
mous
carri
human
polio
viru
receptor
gene
develop
neurogen
virul
test
abe
et
al
nagata
et
al
global
drive
erad
polio
probabl
continu
depend
macaqu
model
test
neurogen
virul
oral
vaccin
importantli
macaqu
use
recent
polioviru
pathogen
studi
samuel
et
al
effort
develop
hexaval
vaccin
inactiv
polioviru
influenza
hepat
b
diphtheria
tetanu
pertussi
caulfield
et
al
despit
avail
licens
vaccin
sinc
measl
lead
caus
vaccineprevent
childhood
mortal
worldwid
respons
estim
death
inadvert
transmiss
either
viru
human
close
relat
distemp
viru
dog
captiv
macaqu
caus
numer
outbreak
signific
morbid
mortal
choi
et
al
jonesengel
et
al
willi
et
al
experiment
inocul
wild
measl
viru
strain
macaqu
produc
diseas
close
mimic
human
measl
clinic
patholog
manifest
includ
immunosuppress
occasion
central
nervou
system
complic
albrecht
et
al
kobun
et
al
undetect
cn
infect
macaqu
measl
viru
may
affect
result
neurovirul
test
done
oral
polioviru
vaccin
contrera
furesz
anim
model
particularli
valuabl
studi
measl
viru
pathogenesi
normal
immunocompromis
host
hick
et
al
polack
et
al
zhu
et
al
cellular
immun
appear
import
humor
immun
clearanc
viru
pahar
et
al
permar
et
al
past
decad
investig
taken
advantag
excel
diseas
model
test
new
vaccin
strategi
adult
macaqu
immun
either
human
measl
viru
vaccin
attenuvax
canin
distemp
viru
vaccin
protect
challeng
infect
human
measl
viru
christ
et
al
matern
measl
viru
antibodi
interfer
activ
immun
respons
experi
done
infant
macaqu
compar
sever
recombin
vaccin
given
presenc
absenc
preexist
immun
least
partial
protect
challeng
infect
diseas
achiev
infant
macaqu
presenc
matern
antibodi
measl
viru
vaccin
replicationcompet
defect
vaccinia
viru
express
measl
viru
hemagglutinin
fusion
protein
stittelaar
et
al
zhu
et
al
recombin
bcg
express
measl
viru
nucleoprotein
zhu
et
al
measl
viru
dna
vaccin
premenkolani
et
al
addit
interleukin
recombin
measl
viru
vaccin
alter
helper
type
immun
respons
improv
immunosuppress
associ
challeng
infect
hoffman
et
al
recent
live
attenu
measl
viru
vaccin
given
aerosol
administr
efficaci
macaqu
de
swart
et
al
goal
global
initi
measl
reduc
measl
mortal
use
current
vaccin
countri
high
measl
death
india
indonesia
pakistan
macaqu
model
essenti
defin
effect
antimeasl
vaccin
regimen
achiev
goal
simian
varicella
viru
svv
share
genet
ident
human
varicella
chickenpox
herp
zoster
shingl
viru
vzv
gray
oak
simian
varicella
viru
svv
caus
highli
contagi
diseas
often
fatal
old
world
monkey
includ
macaqu
wenner
et
al
known
whether
monkey
natur
host
viru
evid
svv
infect
human
svv
infect
macaqu
similar
clinic
symptom
pathogenesi
vzv
infect
human
therefor
provid
excel
model
gray
like
vzv
svv
establish
lifelong
latent
infect
neural
ganglia
may
reactiv
eg
gamma
irradi
antivir
therapi
effect
limit
fatal
svv
epizoot
lakebakaar
et
al
entir
svv
genom
clone
sequenc
transfect
vero
cell
yield
infecti
viru
allow
sitespecif
mutagenesi
insert
foreign
gene
studi
pathogenesi
viral
latenc
develop
vaccin
gray
et
al
current
live
attenu
vzv
vaccin
gener
safe
human
concern
durat
efficaci
safeti
macaqu
offer
opportun
evalu
new
attenu
vzv
vaccin
well
subunit
dna
vaccin
respiratori
syncyti
viru
rsv
major
caus
sever
respiratori
diseas
infant
elderli
human
young
macaqu
suscept
experiment
rsv
infect
exhibit
mild
clinic
diseas
mcarthurvaughan
gershwin
simo
et
al
inactiv
rsv
vaccin
develop
caus
enhanc
diseas
natur
infect
research
reproduc
immunopatholog
phenomenon
macaqu
show
caus
antibodydepend
enhanc
rsv
replic
ponnuraj
et
al
vaccineinduc
hypersensit
subsequ
rsv
infect
also
contribut
least
part
advers
reaction
de
swart
et
al
macaqu
model
prove
help
assess
safeti
novel
rsv
vaccin
design
prevent
immunopatholog
occur
rsv
infect
de
waal
et
al
newli
discov
human
paramyxoviru
caus
agent
acut
lower
respiratori
tract
infect
young
children
elderli
immunocompromis
patient
viru
ubiquit
acquir
earli
life
readili
cultur
rhesu
monkey
kidney
cell
recent
experiment
infect
macaqu
metapneumoviru
induc
asymptomat
infect
transient
protect
immun
reinfect
homolog
viru
strain
kuiken
et
al
van
den
hoogen
et
al
cytomegaloviru
infect
macaqu
close
resembl
human
preval
natur
histori
congenit
cmv
infect
human
lead
infecti
caus
birth
defect
newborn
human
macaqu
cmv
gener
present
puberti
asymptomat
lifelong
infect
vogel
et
al
rhesu
macaqu
experiment
infect
rhesu
cmv
seroconvert
becam
infect
remain
healthi
lockridg
et
al
rhesu
cmv
complet
sequenc
protein
similar
human
cmv
protein
hansen
et
al
rhesu
cmv
encod
protein
immunosuppress
properti
lockridg
et
al
spencer
et
al
reactiv
cmv
associ
inflamm
occur
immunosuppress
human
macaqu
dramat
evid
human
simian
aid
macaqu
experiment
infect
rhesu
cmv
siv
show
augment
siv
pathogenesi
sequar
et
al
rhesu
cmv
strong
affin
endotheli
cell
encod
viral
homologu
carlson
et
al
rue
et
al
macaqu
model
intrauterin
rhesu
cmv
infect
exhibit
rang
development
abnorm
similar
observ
human
congenit
infect
cmv
barri
et
al
tarant
et
al
develop
effect
cmv
vaccin
prevent
congenit
infect
high
public
health
prioriti
initi
result
indic
rhesu
cmv
dna
vaccin
target
glycoprotein
b
phosphoprotein
viral
induc
low
level
neutral
antibodi
decreas
viral
load
challeng
yue
et
al
work
macaqu
model
requir
improv
level
vaccin
protect
b
viru
alphaherpesviru
complet
sequenc
perelygina
et
al
macaqu
counterpart
herp
simplex
viru
hsv
human
like
hsv
b
viru
produc
ubiquit
lifelong
infect
macaqu
present
almost
colonybr
anim
enzoot
infect
popul
time
reach
sexual
matur
jainkittivong
langlai
reactiv
viru
usual
asymptomat
may
occasion
caus
cold
sore
gingiv
even
fatal
system
infect
carlson
et
al
interestingli
coinfect
macaqu
siv
simian
type
retroviru
seldom
caus
activ
latent
b
viru
despit
frequent
activ
latent
herpesvirus
eg
cmv
epsteinbarr
viru
among
herpesvirus
identifi
nonhuman
primat
b
viru
one
known
pathogen
human
case
zoonot
b
viru
infect
report
four
decad
high
incid
enceph
death
ostrowski
et
al
rapid
treatment
antivir
medic
prevent
diseas
complic
new
antivir
drug
develop
focher
et
al
vaccin
could
prevent
limit
b
viru
infect
macaqu
would
lessen
occup
risk
individu
handl
anim
end
inactiv
b
viru
vaccin
test
immunogen
macaqu
hull
vaccinia
viru
express
glycoprotein
given
rabbit
confer
good
protect
b
viru
challeng
infect
bennett
et
al
recent
immunogen
dna
vaccin
b
viru
test
mice
uninfect
rhesu
macaqu
loomishuff
et
al
low
level
b
viru
neutral
antibodi
induc
monkey
challeng
futur
vaccin
combin
includ
live
vector
vaccinia
viru
aim
elicit
cellmedi
immun
import
protect
b
viru
lymphotrop
herpesviru
caus
roseola
infantum
human
determin
whether
might
acceler
progress
aid
hivinfect
peopl
research
coinfect
pigtail
macaqu
siv
infect
alon
speci
asymptomat
yalcin
et
al
presenc
siv
appear
acceler
aid
progress
lusso
et
al
yalcin
et
al
also
vitro
infect
macaqu
lymphocyt
increas
level
siv
replic
lusso
et
al
macaqu
model
may
help
investig
viral
host
factor
influenc
interact
hiv
progress
aid
base
serolog
relat
yet
unidentifi
herpesviru
may
present
squirrel
monkey
macaqu
higashi
et
al
yellow
fever
viru
first
describ
human
pathogen
transmit
insect
aed
aegypti
mosquito
research
found
rhesu
macaqu
suscept
experiment
induct
classic
yellow
fever
filter
human
blood
use
anim
model
success
appli
koch
postul
viru
infect
first
time
virolog
stoke
et
al
almost
year
later
complet
genom
sequenc
ae
aegypti
report
nene
et
al
natur
sourc
yellow
fever
viru
monkey
origin
tropic
west
africa
spread
infect
human
aed
mosquito
viru
adapt
america
interestingli
yellow
fever
viru
never
report
asia
despit
presenc
ae
aegypti
mosquito
control
led
erad
viru
cuba
panama
begin
centuri
first
yellow
fever
vaccin
made
brain
experiment
infect
macaqu
graff
later
attenu
live
vaccin
prepar
chick
embryo
neurotrop
immunogen
properti
test
macaqu
mason
et
al
seed
viru
sourc
current
human
vaccin
proven
stabl
safe
efficaci
given
singl
dose
howev
occasion
case
fatal
hemorrhag
fever
recent
associ
vaccin
vasconcelo
et
al
therefor
qualiti
control
test
potenti
neurovirul
vaccin
continu
rhesu
monkey
marchevski
et
al
yellow
fever
vaccin
strain
also
provid
vector
recombin
chimer
vaccin
flavivirus
japanes
enceph
chikungunya
west
nile
dengu
virus
vaccin
reli
rhesu
monkey
proof
efficaci
neurovirul
safeti
test
discuss
epidem
dengu
becom
common
sinc
second
malaria
import
mosquitoborn
ae
aegypti
diseas
affect
human
global
distribut
dengu
expand
compar
malaria
year
million
case
dengu
fever
occur
exhibit
sever
dengu
hemorrhag
fever
case
fatal
rate
dengu
agent
belong
one
four
viru
serotyp
genu
flaviviru
cross
protect
serotyp
epidem
caus
multipl
serotyp
hemorrhag
fever
associ
superinfect
dengu
viru
serotyp
distinct
serotyp
primari
infect
possibl
via
mechan
antibodydepend
enhanc
viru
uptak
replic
investig
document
natur
asymptomat
infect
macaqu
southeast
asia
dengu
flavivirus
eg
japanes
enceph
chikungunya
sindbi
virus
suggest
possibl
sylvat
transmiss
cycl
inou
et
al
peiri
et
al
licens
vaccin
dengu
avail
recent
progress
sever
recombin
live
attenu
dengu
viru
vaccin
macaqu
rhesu
monkey
quit
suscept
experiment
infect
dengu
viru
provid
import
anim
model
pathogenesi
treatment
vaccin
develop
use
dna
microarray
pcr
multiplex
cytokin
detect
research
shown
transcript
activ
innat
antivir
immun
respons
upregul
certain
cytokin
gene
day
infect
dengu
viru
type
sariol
et
al
attempt
suppress
dengu
viru
type
earli
viremia
rhesu
monkey
recombin
human
alpha
interferon
show
temporari
suppress
viremia
effect
total
viral
burden
ajariyakhajorn
et
al
recombin
modifi
vaccinia
viru
express
envelop
glycoprotein
dengu
type
viru
protect
rhesu
monkey
homolog
viral
challeng
men
et
al
recombin
modifi
live
chimer
yellow
feverdengu
type
viru
vaccin
chimerivax
protect
rhesu
monkey
challeng
wildtyp
dengu
type
viru
guirakhoo
et
al
protect
correl
product
neutral
antibodi
vaccin
phase
clinic
trial
recent
tetraval
live
attenu
dengu
viru
vaccin
given
rhesu
macaqu
provid
complet
protect
viremia
dengu
type
challeng
partial
protect
three
serotyp
blaney
et
al
sun
et
al
interfer
among
four
vaccin
virus
requir
dose
adjust
identifi
optim
formul
human
avail
infecti
cdna
clone
sever
flavivirus
made
possibl
construct
new
live
chimer
flaviviru
vaccin
bear
attenu
mutat
protect
antigen
variou
highli
virul
well
attenu
flavivirus
may
prove
use
immun
divers
flavivirus
public
health
signific
exampl
yellow
fever
viru
chimera
express
envelop
gene
japanes
enceph
viru
anoth
flaviviru
protect
macaqu
homolog
viru
challeng
see
live
dengu
viru
chimera
bear
envelop
glycoprotein
gene
avirul
tickborn
flaviviru
langat
viru
protect
rhesu
monkey
infect
highli
virul
close
relat
tickborn
flavivirus
pletnev
et
al
spread
mosquito
aegypti
albopictu
chikungunya
viru
caus
signific
outbreak
diseas
similar
dengu
tanganyika
northern
india
malaysia
recent
itali
pialoux
et
al
name
deriv
makond
tanganyika
word
mean
bend
refer
stoop
postur
develop
result
diseas
arthrit
symptom
macaqu
suscept
experiment
infect
therefor
use
studi
mosquito
transmiss
viru
paul
singh
feasibl
develop
inactiv
nakao
hotta
attenu
turel
malinoski
viral
vaccin
rapid
reemerg
chikungunya
viru
rel
lack
knowledg
mechan
pathogenesi
lack
effect
vaccin
therapi
macaqu
valuabl
address
critic
issu
virushost
relationship
develop
intervent
japanes
enceph
viru
jev
one
import
caus
viral
enceph
worldwid
spread
throughout
china
southeast
asia
indian
subcontin
filter
agent
respons
fatal
enceph
first
shown
experiment
transmiss
jev
macaqu
karlen
viru
later
shown
transmit
wild
domest
bird
pig
culex
mosquito
formalinkil
attenu
live
vaccin
use
mani
year
kill
vaccin
given
second
world
war
protect
american
troop
asia
rhesu
macaqu
highli
suscept
lethal
infect
resembl
fatal
human
diseas
intranas
inocul
jev
myint
et
al
recent
year
macaqu
use
test
sever
recombin
flaviviru
vaccin
includ
jev
west
nile
viru
dean
et
al
monath
et
al
raengsakulrach
et
al
anoth
studi
investig
show
bonnet
macaqu
immun
jev
vaccin
protect
west
nile
viru
wherea
west
nile
viru
immun
reduc
sever
jev
diseas
goverdhan
et
al
mosquitoborn
tropic
diseas
viru
caus
major
morbid
mortal
livestock
human
subsaharan
africa
rhesu
macaqu
quit
suscept
experiment
infect
develop
sever
hemorrhag
diseas
peter
et
al
use
show
benefici
effect
antivir
drug
alpha
interferon
treatment
protect
viremia
hemorrhag
liver
damag
soon
infect
cosgriff
et
al
morril
et
al
peter
et
al
formalinkil
mutagenattenu
vaccin
show
partial
protect
challeng
infect
diseas
rhesu
monkey
morril
peter
anim
model
also
suitabl
develop
new
method
rapid
diagnosi
therapi
dissemin
intravascular
coagul
dic
hemorrhag
occur
sever
diseas
among
numer
arenavirus
four
known
caus
diseas
human
infect
lcm
viru
lcmv
lassa
viru
model
macaqu
lcm
viru
acquir
rodent
origin
old
world
worldwid
distribut
common
hous
mice
mu
musculu
carri
lcmv
asymptomat
pet
hamster
becom
infect
contact
wild
mice
human
infect
may
asymptomat
result
mild
febril
ill
acut
mening
especi
laboratori
exposur
guinea
lcmv
congenit
infect
caus
hydrocephalu
fetal
death
persontoperson
transmiss
report
contrast
lassa
viru
local
west
africa
also
acquir
rodent
capabl
caus
sever
often
fatal
diseas
minor
infect
human
lassa
fever
viru
spread
human
manifest
hepat
diffus
hemorrhag
cn
damag
experiment
infect
rhesu
monkey
lcm
viru
given
intraven
result
uniformli
fatal
hemorrhag
fever
encephalopathi
walker
et
al
wherea
viru
given
intragastr
induc
spectrum
clinic
outcom
characterist
lassa
viru
infect
human
lukashevich
et
al
macaqu
infect
intragastr
rout
protect
lethal
diseas
challeng
later
intraven
rout
protect
correl
best
strong
cellmedi
immun
roda
et
al
last
year
research
establish
lcmv
infect
macaqu
surrog
lassa
viru
infect
human
djavani
et
al
transcriptom
macaqu
experiment
infect
lcm
viru
show
weak
inflammatori
respons
upregul
express
evid
hepatocyt
prolifer
blood
chang
indic
major
alter
eicosanoid
immun
respons
hormon
respons
pathway
lukashevich
et
al
research
earli
show
rhesu
monkey
also
suscept
lethal
infect
lassa
viru
ribavirin
treatment
immun
plasma
benefici
jahrl
et
al
studi
show
shock
macaqu
model
lassa
fever
due
biochem
dysfunct
platelet
endotheli
cell
lead
leakag
plasma
hemorrhag
fisherhoch
et
al
passiv
antibodi
therapi
alon
combin
ribavirin
effect
cynomolgu
macaqu
infect
lassa
viru
jahrl
peter
report
rhesu
monkey
protect
fatal
lassa
fever
vaccin
recombin
vaccinia
viru
contain
lassa
viru
glycoprotein
fisherhoch
et
al
work
macaqu
confirm
efficaci
safeti
vaccin
establish
suitabl
evalu
human
fisherhoch
et
al
research
recent
report
new
effect
vaccin
prevent
experiment
lassa
fever
macaqu
immun
vesicular
stomat
viru
carrier
genet
materi
lassa
viru
geisbert
et
al
natur
occur
leprosi
document
chimpanze
sooti
mangabey
wildcaught
cynomolgu
macaqu
valverd
et
al
experiment
infect
rhesu
macaqu
lepra
caus
clinic
leprosi
gormu
et
al
wolf
et
al
coinfect
siv
increas
suscept
impair
respons
lepra
antigen
probabl
loss
cell
bcg
vaccin
protect
rhesu
monkey
experiment
leprosi
gormu
et
al
experiment
attempt
transmit
lepra
sooti
mangabey
rhesu
macaqu
earli
led
inadvert
transmiss
siv
induct
said
murpheycorb
et
al
buruli
ulcer
socal
neglect
tropic
diseas
hotez
et
al
caus
mycobacterium
ulceran
present
disfigur
skin
ulcer
togeth
tuberculosi
leprosi
mycobacteri
diseas
becom
major
health
problem
countri
particularli
central
africa
ulceran
first
identifi
environ
use
pcr
amplif
method
aquat
insect
obtain
endem
area
africa
thu
transmiss
may
occur
bite
water
bug
insect
order
hemiptera
johnson
et
al
southeastern
australia
recent
outbreak
buruli
ulcer
probabl
transmit
mosquito
johnson
et
al
specif
vaccin
avail
crossprotect
efficaci
ulceran
experiment
infect
achiev
mice
vaccin
either
bcg
plasmid
dna
encod
antigen
tuberculosi
tangh
et
al
howev
lack
experiment
anim
model
replic
spectrum
human
diseas
featur
particular
extens
ulcer
prompt
studi
intraderm
inocul
cynomolgu
monkey
ulceran
walsh
et
al
inocul
site
develop
ulcer
within
week
size
rate
progress
proport
number
organ
deliv
macaqu
may
thu
provid
valuabl
model
vaccin
develop
ulceran
louseborn
rickettsia
r
prowazekii
r
tsutsugamushi
caus
epidem
typhu
scrub
typhu
respect
affect
cours
human
histori
epidem
armi
crowd
popul
poor
hygien
live
attenu
vaccin
r
prowazekii
develop
use
human
accompani
substanti
incid
side
effect
includ
mild
form
typhu
cynomolgu
macaqu
suscept
experiment
epidem
typhu
infect
gonder
et
al
serv
model
develop
scrub
typhu
vaccin
made
either
recombin
outer
membran
protein
chattopadhyay
et
al
dna
ni
et
al
infect
macaqu
develop
r
tsutsugamushi
antigenspecif
cellmedi
immun
respons
macmillan
et
al
vaccin
made
outer
membran
protein
r
tsutsugamushi
induc
humor
cellular
immun
respons
effect
attenu
live
vaccin
prevent
infect
macaqu
howev
vaccin
abl
reduc
inflamm
site
inocul
chattopadhyay
et
al
consid
worldwid
incid
malaria
million
clinic
case
million
death
annual
need
protect
measur
includ
vaccin
remain
imper
increas
drug
resist
among
malari
parasit
add
difficulti
malaria
control
four
speci
parasit
infect
human
p
falciparum
avian
origin
caus
death
africa
p
vivax
macaqu
origin
account
infect
outsid
africa
africa
escalant
et
al
macaqu
suscept
experiment
infect
sporozoit
p
falciparum
p
vivax
well
relat
indigen
plasmodium
speci
eg
p
cynomolgi
p
fragil
p
coatneyi
kawai
et
al
natur
experiment
infect
caus
clinic
malaria
variou
antimalari
drug
success
elimin
parasitemia
puri
dutta
wengelnik
et
al
experiment
studi
pathogenesi
vaccinolog
use
p
falciparum
p
vivax
indigen
macaqu
plasmodium
speci
research
publish
complet
genom
sequenc
anophel
gambia
primari
mosquito
vector
malaria
africa
gardner
et
al
three
gener
type
malari
vaccin
research
develop
target
circumsporozoit
cs
protein
express
extracellular
sporozoit
intracellular
hepat
stage
parasit
induc
steril
immun
target
bloodstag
merozoit
reduc
diseas
burden
target
zygot
develop
mosquito
host
block
transmiss
vaccin
research
focus
block
initi
infect
use
irradi
kill
sporozoit
cs
surfac
protein
recombin
hepat
b
viru
surfac
core
antigen
adenoviru
recombin
nake
dna
variou
combin
protocol
heppner
et
al
walsh
et
al
wu
et
al
experi
use
mice
human
macaqu
also
use
immunogen
efficaci
safeti
test
well
vaccin
test
aim
recombin
surfac
protein
merozoit
zygot
stage
coban
et
al
dutta
et
al
three
vaccin
approach
shown
degre
efficaci
mice
macaqu
human
suffici
magnitud
support
widespread
clinic
applic
recent
transcript
profil
host
gene
express
whole
white
blood
cell
test
rhesu
monkey
model
human
p
vivax
malaria
result
indic
downregul
gene
involv
rna
process
initi
liver
stage
infect
upregul
defens
respons
gene
ylostalo
et
al
macaqu
model
may
yet
direct
research
effort
toward
better
vaccin
novel
target
therapi
sever
schistosomia
speci
parasit
trematod
infect
million
peopl
tropic
subtrop
countri
although
mortal
low
schistosomiasi
debilit
infect
individu
snail
intermedi
host
cercaria
infect
mammal
penetr
skin
migrat
hematogen
mani
organ
worm
egg
caus
inflamm
mansoni
primarili
affect
liver
interestingli
haematobium
caus
squamou
cell
carcinoma
bladder
egypt
macaqu
suscept
experiment
infect
mansoni
maddison
et
al
meisenheld
thompson
juvenil
rhesu
monkey
appear
suscept
infect
perhap
reduc
type
cytokin
respons
fallon
et
al
rhesu
monkey
proven
use
understand
immunolog
schistosomiasi
develop
solid
immun
reinfect
vaccin
surfac
antigen
gave
partial
protect
challeng
cynomolgu
monkey
smith
clegg
rhesu
monkey
chronic
infect
shiv
clade
c
coinfect
mansoni
reactiv
viral
replic
increas
express
cytokin
respons
ayashrashkovski
et
al
chenin
et
al
find
suggest
parasiteinfect
human
may
suscept
infect
chaga
diseas
occur
primarili
rural
area
south
america
interestingli
absent
old
world
pathogen
agent
flagel
protozoan
name
cruzi
relat
agent
african
sleep
sick
protozoa
transmit
human
bite
triatomid
kiss
bug
larg
natur
reservoir
organ
includ
infect
human
domest
anim
wild
anim
rodent
monkey
infect
describ
freerang
captiv
macaqu
kasa
et
al
olson
et
al
pung
et
al
charl
darwin
may
acquir
diseas
ie
cardiomyopathi
morri
et
al
bite
call
great
black
bug
pampa
reduviu
vinchuca
darwin
acut
phase
exhibit
skin
nodul
site
bite
usual
head
local
lymphadenopathi
chronic
diseas
affect
nervou
system
digest
system
heart
caus
death
annual
mostli
heart
failur
due
associ
cardiomyopathi
acut
chronic
chaga
diseas
model
establish
rhesu
bonecinialmeida
mda
et
al
carvalho
et
al
acut
phase
includ
parasitemia
circul
specif
igm
igg
antibodi
hematolog
alter
chronic
diseas
occur
year
infect
sever
cardiac
damag
scientist
recent
report
sivinduc
immunosupress
reactiv
previous
unnot
chronic
infect
chaga
diseas
rhesu
monkey
kunz
et
al
african
sleep
sick
major
concern
african
countri
particularli
east
centralwest
africa
caus
subspeci
protozoan
trypanosoma
brucei
tb
gambiens
tb
rhodesiens
respect
diseas
uniformli
fatal
untreat
eastern
version
zoonosi
cattl
main
reservoir
human
major
reservoir
western
version
less
virul
rhesu
macaqu
infect
tb
rhodesiens
develop
glomerulonephr
associ
activ
altern
complement
pathway
nagl
et
al
develop
antibodi
nucleic
acid
lindsley
et
al
stumptail
macaqu
experiment
infect
tb
rhodesiens
show
neurolog
sign
raether
seidenath
vaccin
earli
treatment
trypanocid
drug
diamidin
effect
elimin
parasit
blood
ascariasi
global
preval
approxim
million
consid
major
neglect
tropic
diseas
hotez
et
al
fatal
baylisascari
larva
migran
acquir
raccoon
fece
occur
spontan
coloni
japanes
macaqu
sato
et
al
stumptail
macaqu
experiment
infect
nematod
ascari
suum
serv
model
allerg
bronchiti
particular
releas
histamin
leukotrien
prostaglandin
bronchoalveolar
mast
cell
well
et
al
lymphat
filariasi
caus
massiv
lymphedema
elephantiasi
approxim
million
peopl
throughout
tropic
hotez
et
al
investig
whether
wolbachia
symbiot
bacteria
filari
nematod
contribut
diseas
progress
research
establish
rhesu
monkey
model
filariasi
found
monkey
infect
filari
brugia
malayi
develop
antibodi
specif
wolbachia
surfac
protein
well
antifilari
antibodi
associ
lymphedema
develop
punkosdi
et
al
find
suggest
wolbachia
may
critic
pathogenesi
elephantiasi
draft
genom
b
malayi
predict
protein
whose
analysi
provid
insight
molecular
basi
mutual
relationship
wolbachia
endosymbiont
ghedin
et
al
inform
serv
basi
ration
drug
design
filariasi
onchocerciasi
river
blind
major
caus
blind
associ
chorioretin
elicit
onchocerca
volvulu
microfilaria
lesion
resembl
human
diseas
induc
inject
live
volvulu
microfilaria
isol
infect
human
eye
cynomolgu
monkey
donnelli
et
al
semba
et
al
recent
year
howev
river
blind
nearli
elimin
treatment
antihelminth
drug
ivermectin
thu
negat
need
anim
model
human
papillomavirus
hpv
caus
cervic
cancer
human
therefor
basi
recent
releas
vaccin
cervic
cancer
rhesu
macaqu
sever
differ
primat
facil
infect
indigen
papillomavirus
ostrow
et
al
pcr
analysi
genit
sampl
femal
cynomolgu
rhesu
monkey
also
show
natur
host
genit
papillomavirus
genet
relat
genet
divers
similar
hpv
chan
et
al
cervic
vagin
epitheli
neoplasm
associ
papillomaviru
present
captiv
femal
cynomolgu
macaqu
wood
et
al
four
viral
type
associ
cervic
intraepitheli
neoplasia
cin
resembl
human
cin
transfer
cervic
cell
posit
one
highrisk
papillomaviru
type
close
relat
highli
oncogen
uninfect
monkey
result
new
cervic
infect
develop
abnorm
cytolog
wood
et
al
cin
squamou
cell
carcinoma
cervix
result
sexual
transmiss
papillomaviru
rhesu
monkey
ostrow
et
al
macaqu
papillomaviru
model
prove
valuabl
research
pathogenesi
therapi
prevent
cervic
cancer
intrathec
inocul
pallidum
rhesu
macaqu
becam
infect
clear
infect
central
nervou
system
cn
happen
human
earli
syphili
marra
et
al
local
product
gamma
interferon
appear
contribut
process
follow
intraderm
inocul
infect
macaqu
develop
primari
secondari
syphilit
lesion
presenc
siv
coinfect
exhibit
delay
clearanc
pallidum
site
infect
impair
humor
immun
respons
agent
marra
et
al
chlamydia
common
sexual
transmit
diseas
unit
state
almost
million
case
report
annual
center
diseas
control
prevent
cdc
caus
microb
chlamydia
trachomati
gramneg
oblig
intracellular
bacterium
pass
infect
mother
babi
birth
canal
caus
trachoma
diseas
character
conjunct
lead
blind
half
infant
chlamydia
call
silent
diseas
infect
women
men
symptom
untreat
infect
caus
pelvic
inflammatori
diseas
may
lead
infertil
ectop
pregnanc
agent
also
enhanc
likelihood
infect
hiv
sequenc
genom
contain
million
base
pair
code
open
read
frame
includ
numer
potenti
virulenceassoci
protein
stephen
et
al
macaqu
serv
use
model
aspect
c
trachomati
infect
intraocular
inocul
produc
conjunct
trachoma
taylor
et
al
either
complet
prevent
oral
vaccin
attenu
kill
bacteria
taylor
et
al
reduc
sever
vaccin
made
major
outer
membran
protein
campo
et
al
vaccin
protect
appear
correl
induct
cellmedi
immun
respons
intrarect
intratub
inocul
macaqu
caus
proctiti
quinn
et
al
salpig
patton
respect
proven
use
understand
pathogenesi
van
voorhi
et
al
evalu
system
antibiot
eg
azithromycin
patton
et
al
topic
microbicid
patton
et
al
research
found
antibodi
c
trachomati
heat
shock
protein
peel
et
al
two
protein
includ
heat
shock
protein
local
bacteri
inclus
bodi
bannantin
rockey
marker
persist
infect
delayedtyp
hypersensit
reaction
lichtenwaln
et
al
west
nile
viru
wnv
spread
mosquito
first
appear
northeastern
unit
state
gradual
spread
across
north
american
contin
caus
approxim
report
human
case
viru
also
infect
bird
hors
often
lethal
well
macaqu
cohen
et
al
ratterre
et
al
milder
symptom
live
attenu
recombin
vaccin
construct
infecti
clone
yellow
fever
viru
envelop
gene
wnv
replac
arroyo
et
al
preclin
immunogen
efficaci
test
macaqu
show
vaccin
induc
strong
wnvspecif
neutral
antibodi
cell
respons
efficaci
safe
monath
et
al
vaccin
licens
use
hors
yet
human
hantavirus
maintain
rodent
reservoir
caus
two
sever
human
diseas
hemorrhag
fever
renal
syndrom
hfr
hantaviru
pulmonari
syndrom
hp
diseas
featur
vascularleak
syndrom
hemorrhag
manifest
often
fatal
approxim
case
report
annual
experiment
hantaviru
infect
puumala
and
prospect
hill
strain
cynomolgu
macaqu
result
rel
mild
form
hfr
groen
et
al
mcelroy
et
al
cytokin
induct
viral
rna
monitor
blood
anim
klingstrom
et
al
passiv
transfer
neutral
antibodi
rhesu
macaqu
immun
hp
and
viru
dna
vaccin
strongli
protect
highli
suscept
hamster
experiment
infect
and
viru
hooper
et
al
dna
antibodi
also
neutral
virus
caus
hfr
hp
custer
et
al
emerg
sar
affect
global
health
caus
major
econom
disrupt
macaqu
inject
variou
rout
caus
coronaviru
sarscov
includ
infecti
molecular
clone
initi
transmiss
sarscov
cynomolgu
macaqu
help
prove
viru
primari
caus
sar
kuiken
et
al
mild
form
diseas
induc
minim
clinic
symptom
rapid
clearanc
viru
resolut
pneumonia
howev
paramet
infect
suffici
appar
possibl
show
benefit
therapi
sirna
given
either
prophylact
therapeut
li
et
al
pegyl
alpha
interferon
also
benefici
effect
sarscov
infect
macaqu
haagman
et
al
inactiv
sarscov
vaccin
zhou
et
al
adenovir
gao
et
al
vaccinia
ankara
viru
recombin
sarscov
chen
et
al
vaccin
show
promis
result
homolog
coronavirus
macaqu
ehrlichia
rickettsi
agent
classifi
famili
ehrlichiaca
oblig
intracellular
bacteria
share
tick
vector
infecti
pathogen
borrelia
burgdorferi
agent
lyme
diseas
rodent
particularli
whitefoot
mice
whitetail
deer
implic
natur
reservoir
granulocyt
ehrlichia
human
granulocyt
ehrlichiosi
first
describ
consid
emerg
human
infecti
diseas
investig
describ
simian
model
rhesu
macaqu
develop
classic
granulocyt
ehrlichiosi
intraven
inocul
hors
blood
infect
ehrlichia
human
fatal
foley
et
al
anim
model
may
import
studi
diagnosi
manag
intervent
pathogenesi
human
granulocyt
ehrlichiosi
lyme
diseas
borreliosi
spirochet
infect
b
burgdorferi
transmit
bite
deer
tick
initi
flulik
syndrom
rash
arthriti
usual
respond
treatment
antibiot
especi
given
earli
cours
ill
howev
patient
receiv
antibiot
develop
poorli
understood
chronic
syndrom
featur
musculoskelet
neurolog
psychiatr
cardiac
manifest
multiantigen
vaccin
pachner
et
al
outer
surfac
protein
vaccin
philipp
et
al
protect
macaqu
lyme
neuroborreliosi
vaccin
lymerix
b
burgdorferi
becam
avail
human
taken
market
safeti
concern
fear
might
trigger
autoimmun
reaction
poor
sale
better
understand
pathogenesi
chronic
lyme
borreliosi
syndrom
investig
inocul
normal
immunosuppress
rhesu
macaqu
caus
spirochet
observ
anim
sever
year
differ
speci
b
burgdorferi
induc
differ
pattern
infect
immun
inflamm
pachner
et
al
transcriptom
spirochet
central
nervou
system
macaqu
show
contrast
profil
depend
steroid
treatment
narasimhan
et
al
research
detect
spirochet
along
accompani
inflamm
month
year
inocul
mening
heart
connect
tissu
elsewher
bodi
particularli
immunosuppress
monkey
bai
et
al
cadavid
et
al
philipp
et
al
robert
et
al
increas
express
b
lymphocyt
proinflammatori
cytokin
detect
muscl
tissu
chronic
infect
rhesu
monkey
pachner
et
al
bartonella
speci
arthropod
bloodborn
intracellular
bacteria
induc
prolong
infect
host
sever
cell
type
particular
erythrocyt
harbor
bartonella
agent
ubiquit
natur
substanti
reservoir
persist
infect
domest
wild
anim
serv
sourc
inadvert
human
infect
breitschwerdt
kordick
infect
anim
human
may
asymptomat
associ
chronic
inflammatori
diseas
bacteremia
agent
widespread
domest
feral
cat
chomel
et
al
zoonot
spread
b
hensela
caus
cat
scratch
diseas
human
diseas
caus
bartonella
speci
trench
fever
b
quintana
oroya
fever
b
bacilliformi
bacillari
angiomatosi
b
quintana
bacteri
endocard
b
hensela
b
quintana
speci
appear
reemerg
often
symptom
persist
bacteremia
immunosuppress
homeless
individu
particularli
infect
foucault
et
al
koehler
et
al
report
natur
infect
b
quintana
captivebr
cynomolgu
macaqu
orourk
et
al
transmiss
rhesu
macaqu
mooser
weyer
studi
b
bacilliformi
agent
oroya
fever
experiment
inocul
young
rhesu
macaqu
induc
symptom
observ
human
case
oroya
fever
noguchi
battistini
recent
develop
macaqu
model
b
quintana
infect
reveal
relationship
chang
outer
membran
protein
differ
virul
properti
bloodstream
infect
zhang
et
al
melioidosi
chronic
infecti
diseas
caus
bacterium
burkholderia
pseudomallei
emerg
diseas
seriou
impact
anim
human
past
centuri
agent
spread
east
asia
mani
previous
unaffect
part
world
infect
human
anim
occur
inocul
ingest
inhal
organ
ubiquit
environ
particularli
soil
mani
speci
domest
farm
wild
anim
well
nonhuman
primat
commonli
infect
hors
diseas
call
glander
recent
review
summar
current
studi
melioidosi
outbreak
anim
includ
nonhuman
primat
spragu
neubauer
macaqu
diseas
may
includ
sever
bronchopneumonia
multipl
abscess
osteomyel
detect
b
pseudomallei
infect
major
challeng
poor
induct
antibodi
accord
one
refer
hubbert
cynomolgu
macaqu
experiment
infect
research
develop
macaqu
model
emerg
pathogen
although
erad
world
vaccinia
viru
vaccin
smallpox
viru
retriev
frozen
stock
pose
signific
threat
agent
bioterror
therefor
improv
drug
perhap
vaccin
urgent
need
purpos
mind
investig
recent
expos
cynomolgu
macaqu
sever
strain
variola
viru
aerosol
intraven
rout
jahrl
et
al
depend
dose
virus
induc
either
uniformli
fatal
diseas
resembl
human
smallpox
less
sever
system
diseas
lower
mortal
high
viru
level
led
multisystem
failur
deplet
cell
dissemin
intravascular
coagul
cdna
microarray
host
gene
express
circul
white
blood
cell
infect
show
upregul
cytokin
includ
alpha
interferon
contribut
cytokin
storm
previous
call
toxemia
rubin
et
al
monkeypox
viru
mpxv
caus
natur
experiment
diseas
cynomolgu
macaqu
similar
human
smallpox
zaucha
et
al
anim
model
help
increas
effect
antivir
drug
candid
novel
smallpox
vaccin
sporad
outbreak
monkeypox
also
occur
human
africa
unit
state
thu
public
health
concern
reservoir
squirrel
small
mammal
monkey
human
accident
host
hutin
et
al
sale
et
al
outbreak
monkeypox
human
central
unit
state
caus
contact
pet
prairi
dog
mammal
ship
gabon
texa
transport
pet
distributor
chicago
area
di
giulio
eckburg
vaccinia
viru
immun
smallpox
vaccin
modifi
vaccinia
viru
ankara
afford
longlast
protect
macaqu
monkeypox
viru
challeng
earl
et
al
heraud
et
al
stittelaar
et
al
vaccin
protect
correl
induct
neutral
antibodi
monkeypox
viru
edghillsmith
et
al
smallpox
vaccin
protect
macaqu
said
lethal
monkeypox
challeng
edghillsmith
et
al
smallpox
dna
vaccin
consist
four
vaccinia
viru
gene
modifi
vaccinia
ankara
dna
vaccin
also
protect
macaqu
otherwis
lethal
challeng
monkeypox
viru
hooper
et
al
nigam
et
al
treatment
macaqu
antivir
compound
cidofovir
hour
lethal
intratrach
mpxv
infect
effect
reduc
mortal
vaccinia
viru
vaccin
stittelaar
et
al
peopl
worldwid
mostli
develop
countri
die
annual
rabi
expens
current
vaccin
deriv
cell
cultur
problem
stabil
effort
way
develop
subunit
dna
vaccin
macaqu
immun
rabi
ribonucleoprotein
protect
challeng
infect
lethal
dose
rabi
viru
tolli
et
al
cynomolgu
macaqu
immun
dna
encod
viral
glycoprotein
surviv
viru
challeng
wherea
nonvaccin
control
develop
fatal
rabi
lodmel
et
al
protect
vaccin
correl
induct
neutral
antibodi
earli
hr
postexposur
treatment
interferon
potent
interferon
induc
also
significantli
reduc
mortal
baer
et
al
weinmann
et
al
earli
day
postexposur
dna
vaccin
given
togeth
human
rabi
immunoglobulin
also
reduc
mortal
marburg
ebola
virus
caus
epidem
hemorrhag
fever
among
virul
virus
infect
human
reservoir
host
africa
known
although
small
mammal
possibl
rodent
bat
suspect
wild
nonhuman
primat
includ
macaqu
like
human
accident
host
virus
usual
transmit
human
contact
infect
anim
summari
marburg
ebola
viru
infect
laboratori
nhp
avail
schou
hansen
total
marburg
ebola
viru
outbreak
report
among
human
monkey
sinc
first
document
outbreak
marburg
germani
human
case
death
occur
africa
contact
infect
patient
ebola
viru
simian
hemorrhag
fever
viru
isol
cynomolgu
macaqu
import
unit
state
philippin
human
anim
handler
becam
infect
get
sick
dalgard
et
al
recent
year
sever
outbreak
human
anim
ebola
gabon
republ
congo
epidem
associ
differ
viral
strain
high
mortal
gorilla
chimpanze
duiker
result
handl
infect
anim
carcass
leroy
et
al
rhesu
cynomolgu
macaqu
highli
suscept
lethal
infect
either
marburg
ebola
viru
geisbert
et
al
ebola
monkey
studi
gain
insight
pathogen
mechan
lead
profound
lymphopenia
dissemin
intravascular
coagul
hemorrhag
septic
shock
characterist
filoviru
infect
human
coagul
abnorm
like
trigger
immunemedi
mechan
rather
direct
damag
endotheli
cell
lymphopenia
attribut
infect
dendrit
cell
block
matur
thu
inhibit
activ
lymphocyt
trigger
bystand
apoptosi
reed
et
al
releas
tissu
factor
monocytemacrophag
key
event
trigger
dissemin
intravascular
coagul
dic
ebola
macaqu
treatment
recombin
inhibitor
tissu
factor
help
prevent
dic
prolong
surviv
geisbert
et
al
contrast
treatment
recombin
alpha
interferon
immunoglobulin
littl
benefit
neutral
antibodi
fail
protect
alter
cours
ebola
viru
infect
monkey
oswald
et
al
live
attenu
recombin
vaccin
protect
macaqu
almost
ebola
marburg
virus
one
vaccin
base
replicationcompet
vesicular
stomat
viru
vsv
express
envelop
glycoprotein
marburg
viru
hevey
et
al
vaccin
induc
cross
protect
two
heterolog
strain
marburg
viru
daddariodicaprio
et
al
also
gave
strong
protect
lethal
marburg
viru
challeng
given
within
minut
viru
inocul
daddariodicaprio
et
al
similar
protect
ebola
marburg
viru
achiev
use
venezuelan
equin
enceph
vee
viru
vector
express
glycoprotein
nucleoprotein
ebola
viru
geisbert
et
al
recombin
adenoviru
carri
ebola
viru
glycoprotein
also
protect
remark
macaqu
receiv
combin
dna
vaccin
marburg
viru
ebola
viru
vee
viru
b
anthraci
develop
protect
immun
agent
riemenschneid
et
al
recent
report
describ
protect
macaqu
ebola
viru
topic
immun
respiratori
tract
human
parainfluenza
viru
type
vaccin
vector
use
express
ebola
viru
surfac
glycoprotein
bukreyev
et
al
aerosol
bacillu
anthraci
spore
consid
foremost
infecti
biolog
threat
unit
state
therefor
import
prepar
stockpil
anthrax
vaccin
macaqu
quit
suscept
experiment
b
anthraci
inhalationinduc
diseas
repres
excel
model
test
vaccin
drug
fritz
et
al
vasconcelo
et
al
studi
year
ago
show
possibl
protect
rhesu
macaqu
inhal
challeng
b
anthraci
spore
cellfre
vaccin
contain
alumprecipit
b
anthraci
toxinderiv
protect
antigen
pa
wright
et
al
vaccin
ava
use
immun
individu
high
risk
occup
exposur
recent
investig
evalu
vaccin
compos
recombin
form
pa
rhesu
macaqu
hepler
et
al
phipp
et
al
williamson
et
al
found
anim
fulli
protect
lethal
dose
aerosol
bacteria
protect
correl
significantli
neutral
antibodi
also
confer
passiv
immun
b
anthraci
challeng
macaqu
dna
vaccin
anthrax
also
efficaci
macaqu
riemenschneid
et
al
transcript
profil
gene
pastimul
peripher
blood
mononuclear
cell
pbmc
anthrax
vaccin
gave
respons
repres
innat
adapt
immun
roger
et
al
studi
predict
pabas
vaccin
efficaci
human
anim
model
also
use
test
antibodi
inhal
anthrax
given
either
alon
togeth
vaccin
kao
et
al
kelli
et
al
francisella
tularensi
zoonot
bacterium
widespread
north
america
well
part
europ
asia
squirrel
rabbit
main
reservoir
transmiss
human
occur
deerfli
mosquito
tick
bite
infect
vertebr
tularemia
seriou
often
fatal
outbreak
natur
acquir
tularemia
also
describ
nonhuman
primat
includ
macaqu
matzrens
et
al
rhesu
macaqu
expos
aerosol
particl
f
tularensi
develop
fullblown
pneumon
form
tularemia
often
fatal
schricker
et
al
macaqu
model
use
year
ago
develop
efficaci
live
attenu
tularemia
vaccin
tuli
et
al
longlast
vaccin
protect
correl
presenc
strong
cellmedi
immun
f
tularensi
spread
rat
flea
macrophagetrop
coccobacillu
one
great
epidem
scourg
human
diseas
larg
disappear
modern
time
due
mostli
improv
rodent
control
howev
direct
humantohuman
aerosol
spread
yersinia
pesti
present
current
bioterror
threat
prompt
effort
develop
plagu
vaccin
case
chronic
pneumon
plagu
rhesu
monkey
report
ransom
krueger
live
attenu
pesti
vaccin
prove
effect
macaqu
meyer
et
al
recent
vaccin
cynomolgu
macaqu
flagellin
tolllik
receptor
agonist
fusion
v
antigen
pesti
induc
strong
antigenspecif
igg
antibodi
respons
protect
lethal
respiratori
challeng
pesti
honko
et
al
williamson
et
al
immun
cynomolgu
macaqu
recombin
pesti
v
antigen
made
plant
vector
system
provid
complet
protect
lethal
challeng
pesti
mett
et
al
brucella
small
nonsporeform
gramneg
coccobacillu
highli
infecti
biolog
warfar
threat
agent
caus
sever
human
ill
bacterium
facult
intracellular
parasit
macrophag
aerosol
exposur
rhesu
macaqu
develop
diseas
similar
human
mens
et
al
perci
et
al
macaqu
immun
live
attenu
strain
b
melitensi
prime
purifi
antigen
solidli
protect
aerosol
challeng
virul
brucella
chen
elberg
protect
correl
induct
antibodi
bacteri
outer
membran
lipopolysaccharid
cytokin
respons
transmiss
spongiform
encephalopathi
infecti
prion
diseas
affect
central
nervou
system
caus
dementia
search
occult
virus
research
inocul
mani
nonhuman
primat
cn
tissu
prepar
human
unexplain
neurodegen
diseas
experi
involv
mani
macaqu
sooti
mangabey
hous
california
nation
primat
research
blind
passag
carri
effort
amplifi
put
human
viru
surprisingli
sever
human
exampl
kuru
restrict
new
guinea
creutzfeldtjakob
diseas
cjd
worldwid
transmiss
chimpanze
gibbon
ape
sever
speci
new
world
monkey
macaqu
espana
et
al
gajdusek
gibb
gibb
gajdusek
master
et
al
diseas
featur
spongiform
noninflammatori
patholog
brain
similar
respect
transmiss
spongiform
encephalopathi
occur
sheep
scrapi
mink
deer
elk
chronic
wast
diseas
cwd
cattl
bovin
spongiform
encephalopathi
bse
spontan
spongiform
encephalopathi
also
observ
young
adult
rhesu
monkey
bon
et
al
diseas
caus
abnorm
fold
protein
aggreg
call
prion
prionassoci
spongiform
encephalopathi
commonli
occur
older
human
alzheim
diseas
infecti
recent
year
cynomolgu
macaqu
inocul
fed
brain
homogen
peopl
variant
cjd
cattl
bse
investig
analyz
involv
peripher
organ
prion
protein
herzog
et
al
bse
agent
readili
adapt
macaqu
exhibit
molecular
characterist
variant
cjd
agent
lasmeza
et
al
larg
amount
prion
protein
present
lymphoid
organ
smaller
amount
nervou
system
lymphoid
organ
blood
thu
repres
high
risk
iatrogen
transmiss
infecti
prion
one
macaqu
develop
variant
cjdlike
neurolog
diseas
year
oral
exposur
bse
agent
lasmeza
et
al
prion
diseas
research
owe
much
progress
macaqu
use
search
unconvent
virus
natur
occur
infect
sever
strain
stlv
highli
preval
asymptomat
african
asian
nonhuman
primat
includ
wild
macaqu
primat
center
zoo
hunsmann
et
al
lowenstin
et
al
miyoshi
et
al
natur
histori
biolog
stlv
similar
human
tlv
watanab
et
al
stlv
htlv
ancient
virus
htlv
appar
aros
contact
stlvinfect
nonhuman
primat
distant
past
recent
studi
document
human
infect
multipl
virus
among
central
african
expos
monkey
either
hous
pet
bush
meat
trade
wolf
et
al
nearli
bush
meat
found
infect
stlv
courgnaud
et
al
evid
found
crossspeci
spread
stlv
primat
handler
unit
state
stlvinfect
macaqu
serv
practic
model
htlv
infect
latent
period
long
decad
tumor
incid
low
unlik
htlv
stlv
link
lymphoma
immunosuppres
neurolog
diseas
macaqu
experiment
coinfect
cynomolgu
macaqu
stlv
siv
show
influenc
stlv
develop
said
fultz
et
al
studi
use
cynomolgu
macaqu
year
ago
show
protect
htlv
challeng
infect
possibl
immun
recombin
envelop
protein
nakamura
et
al
cynomolgu
macaqu
also
protect
stlv
challeng
vaccin
htlv
gag
envelop
subunit
dezzutti
et
al
vaccin
protect
correl
induct
antibodi
envelop
glycoprotein
interestingli
stlv
infect
captiv
baboon
two
primat
facil
sukhumi
primat
center
republ
abkhazia
southwest
region
primat
research
center
san
antonio
texa
link
rel
high
incid
lymphoma
mone
et
al
voevodin
et
al
sukhumi
outbreak
lymphoma
affect
baboon
sinc
molecular
studi
indic
caus
stlv
strain
introduc
baboon
crossspeci
transmiss
rhesu
macaqu
coinfect
baboon
ebvrel
herpesviru
may
cofactor
pathogenesi
lymphoma
schatzl
et
al
could
suitabl
anim
model
htlvassoci
lymphomagenesi
simian
type
retroviru
indigen
retroviru
macaqu
caus
outbreak
immunosuppress
fatal
wast
diseas
cohous
anim
gardner
et
al
prototyp
viru
masonpf
monkey
viru
mpmv
discov
chopra
mason
nt
earli
viru
reemerg
macaqu
sever
primat
center
gardner
et
al
letvin
king
associ
diseas
first
call
simian
aid
said
term
confin
sivinduc
diseas
macaqu
occasion
african
nhp
speci
eg
african
green
sooti
mangabey
monkey
srv
differ
siv
pathogenesi
distantli
relat
hiv
srv
lentiviru
unlik
siv
hiv
srv
caus
gener
infect
b
cell
maul
et
al
genet
stabl
control
neutral
antibodi
whether
induc
natur
vaccin
kwang
et
al
marx
et
al
mani
opportunist
pathogen
associ
siv
hiv
infect
also
exist
macaqu
siv
infect
interestingli
srvinfect
macaqu
major
sourc
kaposi
sarcoma
ks
lesion
call
retroperiton
fibromatosi
rf
see
section
kaposi
sarcoma
contrast
siv
srv
infect
associ
b
cell
lymphoma
activ
latent
ebvlik
viru
although
human
harbor
type
retroviru
suscept
product
infect
srv
includ
import
model
retrovirusinduc
immunosuppress
rf
addit
srv
must
elimin
nhp
use
research
particularli
studi
sivinduc
said
sfv
member
spumaviru
group
ubiquit
macaqu
nonhuman
primat
caus
persist
latent
infect
absenc
diseas
linial
weiss
human
harbor
spumavirus
becom
infect
contact
sfv
carrier
monkey
put
human
foami
viru
isol
probabl
chimpanze
origin
herchenrod
et
al
human
eg
anim
health
worker
african
hunter
accident
infect
sfv
remain
asymptomat
brook
et
al
engel
et
al
jonesengel
et
al
macaqu
harbor
homologu
human
ebv
whose
biolog
macaqu
appear
ident
ebv
human
moghaddam
et
al
complet
sequenc
human
ebv
macaqu
ebvrel
viru
show
strong
similar
rivail
et
al
like
human
ebv
macaqu
viru
gener
caus
lifelong
asymptomat
latent
infect
key
aspect
human
acut
ebv
infect
reproduc
macaqu
model
includ
oral
transmiss
atyp
lymphocytosi
lymphadenopathi
activ
b
cell
featur
infecti
mononucleosi
cytotox
cell
respons
mostli
respons
contain
viru
replic
fogg
et
al
seen
human
aid
macaqu
ebvlik
viru
activ
associ
opportunist
b
cell
lymphoma
occur
cours
sivinduc
simian
aid
posttranspl
immunosuppress
habi
et
al
schmidtko
et
al
activ
ebv
macaqu
also
caus
oral
lesion
call
hairi
cell
leukoplakia
manifest
human
aid
kutok
et
al
immunocompet
immunosuppress
inocul
human
ebv
levin
et
al
rhesu
counterpart
feichting
et
al
moghaddam
et
al
rivail
et
al
develop
lymphoma
rel
short
observ
period
year
less
two
distinct
lineag
retroperiton
fibrosi
rf
herpesviru
rfhv
rhesu
rhadinoviru
rrv
distantli
relat
relat
kaposi
sarcoma
ks
herpesviru
kshv
human
herpesviru
caus
viru
ks
human
schultz
et
al
rfhv
yet
isol
fulli
character
replicationcompet
viru
vitro
associ
spontan
diseas
macaqu
call
retroperiton
fibromatosi
rf
describ
pigtail
macaqu
nemestrina
gidden
et
al
rf
close
resembl
human
ks
histopatholog
except
lack
skin
manifest
rf
tumor
cell
contain
multipl
genom
copi
pattern
infect
latent
antigen
express
similar
human
ks
bruce
et
al
genomewid
transcript
pattern
rrv
close
resembl
transcript
profil
kshv
infect
fibroblast
dittmer
et
al
rrv
infrequ
detect
realtim
pcr
low
level
peripher
blood
healthi
macaqu
frequent
sivinfect
anim
howev
rrv
detect
saidsassoci
lymphoma
lymphoid
hyperplasia
ruff
et
al
experiment
infect
macaqu
rrv
alon
togeth
siv
induc
gener
lymphadenopathi
anim
yet
rf
lesion
lymphoma
estep
et
al
mansfield
et
al
wong
et
al
infecti
isol
molecular
clone
rfhv
eventu
deriv
interest
determin
whether
agent
induc
rf
macaqu
rrv
replic
low
level
induc
specif
patholog
unlik
provid
use
anim
model
diseas
renn
et
al
group
rotavirus
ubiquit
infect
human
year
life
virus
singl
import
caus
sever
diarrhea
infant
young
children
worldwid
nonhuman
primat
includ
macaqu
natur
infect
simian
rotaviru
strain
sever
eg
use
experiment
infect
macaqu
soik
et
al
westerman
et
al
natur
simian
host
diarrhea
usual
manifest
neonat
serum
antibodi
matern
origin
associ
resist
rotaviru
infect
diseas
howev
intragastr
challeng
newborn
infant
cynomolgu
macaqu
simian
rotaviru
strain
induc
diarrhea
petschow
et
al
newborn
macaqu
also
suscept
experiment
infect
diarrheal
diseas
human
rotaviru
isol
leong
awang
majer
et
al
wyatt
et
al
baboon
vervet
monkey
similarli
suscept
experiment
infect
human
rotaviru
develop
diarrhea
chege
et
al
tetraval
rhesushuman
reassort
rotaviru
vaccin
licens
fda
live
attenu
human
vaccin
howev
withdrawn
incid
intussuscept
vaccin
infant
increas
control
murphi
et
al
sever
human
rotaviru
vaccin
current
undergo
human
trial
half
us
outbreak
acut
infecti
nonbacteri
gastroenter
due
norwalk
viru
outbreak
occur
camp
school
nurs
home
cruis
ship
associ
contamin
water
uncook
food
antibodi
viru
protect
human
viru
cultur
vitro
murin
noroviru
isol
replic
cell
cultur
use
studi
pathogenesi
mice
mumphrey
et
al
wobu
et
al
although
neonat
pigtail
macaqu
nemestrina
adult
rhesu
macaqu
suscept
experiment
infect
norwalk
viru
rockx
et
al
subekti
et
al
clinic
gastroenter
exhibit
tickborn
enceph
nontrop
zoonot
diseas
increas
incid
asia
europ
especi
germani
austria
mass
vaccin
campaign
organ
viru
caus
case
enceph
annual
rodent
mainten
host
tbe
transmit
dog
hors
well
human
tbe
viru
isol
speci
tick
main
vector
ixod
persulcatu
ricinu
experiment
infect
macaqu
result
viral
persist
enceph
frolova
et
al
kenyon
et
al
pogodina
et
al
natur
occur
case
tbe
report
macaqu
german
monkey
park
suss
et
al
use
rhesu
monkey
model
intranas
infect
commerci
vaccin
protect
wildtyp
viru
isol
elicit
effect
immun
reaction
without
evid
immun
enhanc
hambleton
et
al
effect
vaccin
avail
individu
risk
suss
simian
hemorrhag
fever
viru
first
isol
palmer
et
al
classifi
arterivirida
famili
smith
et
al
caus
acut
sever
diseas
high
mortal
macaqu
allen
et
al
although
infecti
human
macaqu
diseas
could
model
studi
pathogenesi
viral
hemorrhag
fever
human
human
parvoviru
associ
sever
distinct
clinic
syndrom
includ
sever
anemia
spontan
abort
arthriti
macaqu
commonli
infect
either
natur
experiment
simian
parvoviru
spv
close
relat
human
parvoviru
brown
young
brown
et
al
osullivan
et
al
experiment
inocul
spv
macaqu
induc
temporari
arrest
erythroid
cell
product
analog
observ
infect
human
osullivan
et
al
similarli
midterm
spv
inocul
macaqu
fetus
lead
fetal
hydrop
pcr
detect
parvoviru
infect
monkey
proven
sensit
specif
serolog
gallinella
et
al
although
proven
human
infect
spv
must
consid
potenti
zoonosi
especi
given
abil
viru
replic
human
bone
marrow
cell
vitro
high
level
viremia
develop
infect
macaqu
prototyp
polyomaviru
pv
indigen
macaqu
analog
bk
jc
pv
human
human
aid
macaqu
said
activ
jc
viru
respect
caus
demyelin
cn
diseas
call
progress
multifoc
leukoencephalopathi
genet
analysi
natur
isol
brain
kidney
sever
macaqu
reveal
enhanc
sequenc
organ
differ
laboratori
strain
ilyinskii
et
al
furthermor
anoth
pv
relat
distinct
recent
recov
number
cynomolgu
macaqu
immunosuppress
promot
accept
renal
allograft
xenograft
van
gorder
et
al
viru
call
cpv
caus
interstiti
nephriti
mani
graft
nativ
kidney
well
lateonset
ureter
stenosi
graft
recipi
cpv
repres
excel
model
bk
polyomavirusinduc
interstiti
nephriti
ureter
stenosi
occur
human
renal
transplant
recipi
research
recent
discov
novel
pv
human
patient
acut
respiratori
tract
infect
gaynor
et
al
cynomolgu
macaqu
model
develop
studi
human
diseas
gonder
et
al
macaqu
suscept
experiment
aerosol
infect
coxiella
burnetii
develop
clinic
sign
pulmonari
patholog
characterist
q
fever
infect
human
waag
et
al
kill
c
burnetii
vaccin
provid
partial
protect
infect
diseas
kishimoto
et
al
recent
compar
efficaci
chloroformmethanol
residu
cellular
c
burnetii
vaccin
evalu
macaqu
model
q
fever
waag
et
al
toxigen
strain
e
coli
eg
import
caus
human
morbid
mortal
year
macaqu
serv
model
investig
pathogenesi
treatment
experiment
e
coli
infect
includ
pyelonephr
robert
prostat
neal
et
al
bloodi
diarrhea
kang
et
al
septic
shock
coalson
et
al
immun
shiga
toxin
liposom
conjug
protect
macaqu
lethal
dose
e
coli
shiga
toxin
suzaki
et
al
sever
recent
macaqu
model
experiment
endotox
shock
dissemin
intravascular
coagul
monitor
inflammatori
cytokin
effect
glucocorticoid
treatment
ji
et
al
natur
toxigen
e
coli
infect
describ
sivinfect
infant
adult
rhesu
macaqu
diarrhea
mansfield
et
al
rhesu
e
coli
isol
genet
similar
human
isol
epsilon
intimin
subtyp
enter
bacterium
close
rel
cholera
bacillu
vibrio
cholera
common
agent
infecti
diarrhea
asymptomat
infect
common
human
captiv
macaqu
diseas
individu
may
exhibit
bloodi
diarrhea
morton
et
al
tribe
fleme
campylobact
also
induc
fetal
death
rhesu
monkey
baze
bernacki
anim
contamin
food
sourc
bacteria
rhesu
pigtail
macaqu
suscept
experiment
infect
coliti
human
strain
campylobact
fitzgeorg
et
al
russel
et
al
interestingli
earli
effort
infect
rhesu
monkey
relat
v
cholera
unsuccess
ivanoff
et
al
listeriosi
caus
bacterium
listeria
monocytogen
import
pathogen
human
anim
caus
natur
outbreak
nonhuman
primat
hygien
food
process
storag
remain
best
prevent
measur
human
nonhuman
primat
human
case
occur
immunocompromis
individu
congenit
infect
often
lead
stillbirth
variou
foodstuff
veget
anim
origin
sourc
infect
cynomolgu
macaqu
use
model
infect
l
monocytogen
isol
either
human
nhp
administ
oral
farber
et
al
system
infect
document
shed
bacterium
fece
sever
week
anim
receiv
bacteria
suspend
steril
whole
milk
becam
ill
symptom
septicemia
anorexia
diarrhea
given
pregnant
macaqu
organ
infect
fetu
caus
stillbirth
smith
et
al
rhesu
macaqu
model
aerosol
infect
legionella
pneumophilia
establish
baskervil
et
al
lung
patholog
similar
seen
l
human
document
light
electron
microscopi
guinea
pig
marmoset
equal
suscept
infect
pneumonia
macaqu
model
develop
sever
acut
shigella
dysenteri
among
miser
human
diseas
anim
reservoir
epidem
occur
local
lack
effect
sanit
shigella
outbreak
also
occur
captiv
macaqu
coloni
special
erad
program
may
necessari
control
banish
et
al
line
et
al
mulder
agent
import
occup
zoonosi
kennedi
et
al
research
experiment
infect
rhesu
macaqu
flexneri
investig
pathogenesi
kinsey
et
al
rout
et
al
mucos
invas
colon
essenti
develop
fluid
electrolyt
transport
defect
led
dysenteri
addit
jejun
transport
abnorm
contribut
diarrhea
arthriti
amyloidosi
sivinfect
rhesu
macaqu
associ
flexneri
breakdown
product
intestin
blanchard
et
al
chapman
crowel
urvat
et
al
develop
may
analog
arthriti
increasingli
seen
hiv
patient
free
risk
factor
arthriti
streptococcu
pneumonia
also
known
pneumococcu
diplococcu
long
respons
high
rate
pneumonia
mening
otiti
media
worldwid
particularli
young
children
older
adult
year
ago
rhesu
macaqu
expos
aerosol
influenza
viru
pneumonia
bacteria
clear
lower
respiratori
tissu
persist
upper
respiratori
tract
berendt
et
al
rhesu
monkey
also
serv
model
dissemin
intravascular
coagul
experiment
bloodstream
infect
hawley
et
al
fatal
case
pneumonia
mening
report
liontail
macaqu
silen
baltimor
zoo
graczyk
et
al
sinc
earli
sever
pneumococc
polysaccharid
vaccin
demonstr
effect
infect
older
children
adult
subsequ
immunogen
studi
rhesu
macaqu
led
develop
newer
polysaccharid
vaccin
avail
children
month
age
mcneeli
et
al
howev
adapt
adult
vaccin
necessari
provid
stronger
longerlast
protect
higher
efficaci
immunocompromis
popul
help
answer
need
attempt
way
develop
rhesu
macaqu
model
pneumococc
vaccin
assess
philipp
et
al
group
streptococc
pharyng
result
rheumat
heart
diseas
still
highli
preval
develop
countri
better
understand
pathogenesi
acut
pharyng
aid
develop
effect
streptococc
vaccin
cynomolgu
macaqu
experiment
infect
group
streptococcu
virtaneva
et
al
acut
asymptomat
phase
diseas
identifi
bacteri
colon
sever
throat
inflamm
correl
superantigen
prophag
virul
gene
express
tempor
chang
transcriptom
link
phase
clinic
diseas
host
defens
respons
chronic
enterocol
lead
caus
morbid
captiv
macaqu
recent
survey
fecal
specimen
immunocompet
rhesu
macaqu
without
chronic
diarrhea
reveal
multitud
potenti
enter
bacteri
protozoan
parasit
pathogen
sestak
et
al
organ
associ
chronic
diarrhea
includ
campylobact
shigella
yersinia
adenoviru
strongyloid
enter
pathogen
whether
diarrhea
present
includ
e
coli
carri
shiga
toxin
virul
gene
balantidium
coli
giardia
lamblia
enterocytozoon
microsporidia
trichuri
trichiura
whipworm
microsporidia
could
experiment
transmit
sivinfect
rhesu
monkey
green
et
al
chronic
diarrhea
associ
upregul
certain
cytokin
eg
tnf
tumor
necrosi
factor
alpha
lymphocyt
gutassoci
lymphoid
tissu
roundworm
caus
trichinosi
common
diseas
throughout
world
result
eat
improperli
cook
pork
contain
viabl
cyst
spirali
human
parasit
larva
local
princip
skelet
muscl
evok
gener
myalgia
rhesu
monkey
experiment
infect
year
ago
spirali
larva
develop
trichinosi
show
clinic
patholog
morpholog
similar
human
diseas
cypess
et
al
natur
infect
toxoplasma
gondii
note
sever
speci
asian
macaqu
recent
toqu
macaqu
sinica
sri
lanka
ekanayak
et
al
infect
close
link
human
environ
domest
cat
common
studi
congenit
gondii
infect
research
infect
pregnant
rhesu
stumptail
macaqu
arctoid
protozoa
wong
et
al
signific
neonat
diseas
occur
despit
cn
infect
antivir
treatment
combin
pyrimethamin
sulfadiazin
effect
elimin
parasit
amniot
fluid
neonat
wherea
parasit
detect
untreat
fetus
variou
degre
periodont
diseas
mild
gingiv
necrot
ulcer
gingiv
noma
associ
dental
calculi
present
macaqu
nhp
adam
bishop
cohen
goldman
schiodt
et
al
noma
particularli
associ
srv
type
retroviru
immunosuppress
experiment
periodont
induc
macaqu
placement
periodont
silk
ligatur
orthodont
elast
well
surgic
remov
alveolar
bone
schou
et
al
clinic
patholog
microbiolog
immunolog
characterist
spontan
experiment
periodont
macaqu
similar
human
macaqu
manifest
subgingiv
flora
resembl
found
human
includ
member
actinobacillu
porphyromona
bacteroid
campylobact
fusobacterium
cynomolgu
macaqu
antibodi
titer
rel
level
p
gingivali
invers
correl
suggest
humor
immun
respons
may
efficaci
reduc
overgrowth
bacterium
persson
et
al
thu
macaqu
model
highli
suitabl
develop
vaccin
periodont
survey
illustr
versatil
macaqu
anim
model
translat
human
infecti
diseas
research
addit
natur
infect
macaqu
agent
relat
human
pathogen
extend
valu
anim
major
benefit
research
allevi
infecti
diseas
macaqu
well
primat
speci
compar
studi
human
macaqu
host
need
address
continu
problem
caus
mani
infecti
diseas
remain
intract
factor
increas
travel
popul
growth
chang
ecolog
give
rise
new
emerg
infecti
diseas
recent
advanc
genom
proteom
metabolom
relat
technolog
make
macaqu
model
time
studi
aim
improv
treatment
control
infecti
diseas
human
macaqu
one
medicin
action
